Life science tool companies have traditionally operated in the “research use only” market—selling equipment and reagents to academic labs, research centers and biopharmaceutical R&D. By selling into the research-only market, these companies have been able to avoid the burdens of controls placed on regulated products. However, the line between research and clinical activities is increasingly … Continue reading “The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets”
Author: Jim Prutow
Jim Prutow is a partner at global management consulting firm PRTM (www.prtm.com). He can be reached at [email protected].